Piper Jaffray Downgrades Vitae Pharmaceuticals (VTAE) to Neutral

September 20, 2016 1:37 PM EDT
Get Alerts VTAE Hot Sheet
Price: $20.99 +0.05%

Rating Summary:
    1 Buy, 5 Hold, 0 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 14 | Down: 11 | New: 8
Trade VTAE Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Piper Jaffray downgraded Vitae Pharmaceuticals (NASDAQ: VTAE) from Overweight to Neutral.

For an analyst ratings summary and ratings history on Vitae Pharmaceuticals click here. For more ratings news on Vitae Pharmaceuticals click here.

Shares of Vitae Pharmaceuticals closed at $20.85 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories


Related Entities

Piper Jaffray

Add Your Comment